Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01938638
Title Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer

triple-receptor negative breast cancer

diffuse large B-cell lymphoma

stomach cancer



Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Fayetteville Arkansas 72703 United States Details
Boston Massachusetts 02215 United States Details
Ann Arbor Michigan 48109 United States Details
Hackensack New Jersey 07601 United States Details
New York New York 10032 United States Details
Charleston South Carolina 29425 United States Details
Seoul 05505 Korea, Republic of Details
Seoul 110-744 Korea, Republic of Details
Seoul 120-752 Korea, Republic of Details
Singapore 119228 Singapore Details
Singapore 169610 Singapore Details
Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from for the field